Subsequently, the samples are sequentially stained and treated for antibody removal for 4 markers of interest from the breast cancer panel: estrogen receptor (ER), progesterone receptor (PR), epidermal growth factor receptor 2 (Her2) and cytokeratin (CK). The gene discussed is ERBB2; the disease is breast carcinoma.